General MedicationsINJECTIONGeneric

DAUNORUBICIN HYDROCHLORIDE

Standard Dose

EQ 50MG BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview DAUNORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 064212 (ANDA).

Marketing status: Discontinued Active ingredient DAUNORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2001-12-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview DAUNORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 064212 (ANDA). Marketing status: Discontinued Active ingredient DAUNORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2001-12-10 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.